Literature DB >> 16523327

[Recurrent urinary tract infections in women. Virulence of pathogens and host reaction].

T Oelschlaeger1, R Fünfstück.   

Abstract

The interactions of host-specific and microbial factors are responsible for recurrent urinary tract infections (rUTI). The anatomical properties of the female urogenital tract favor colonization by uropathogens. Local factors such as glucose concentration of the urine, stability of the lactobacilli population, the influence of estrogens, the activity of Tamm-Horsfall protein or of defensins, and disturbance of the systemic defense mechanisms dictate the course of an infection. The most prominent uropathogen is E. coli. It expresses various virulence factors including adhesions, toxins, iron uptake systems, and a capsule. It is still unclear if there are virulence factors characteristic for E. coli strains causing rUTI. The formation of intracellular reservoirs by invasion of uroepithelial cells by E. coli could be another, as yet little noticed cause for rUTI. Therefore, in cases of rUTI the application of intracellularly active antibiotics should be considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16523327     DOI: 10.1007/s00120-006-1020-z

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  24 in total

Review 1.  Covert operations of uropathogenic Escherichia coli within the urinary tract.

Authors:  Jean M Bower; Danelle S Eto; Matthew A Mulvey
Journal:  Traffic       Date:  2005-01       Impact factor: 6.215

2.  Vaccination with purified Dr Fimbriae reduces mortality associated with chronic urinary tract infection due to Escherichia coli bearing Dr adhesin.

Authors:  Pawel Goluszko; Elzbieta Goluszko; Bogdan Nowicki; Stella Nowicki; Vsevolod Popov; Hui-Qun Wang
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism.

Authors:  Marcus D Säemann; Thomas Weichhart; Maximilian Zeyda; Günther Staffler; Michael Schunn; Karl M Stuhlmeier; Yuri Sobanov; Thomas M Stulnig; Shizuo Akira; Alexander von Gabain; Uwe von Ahsen; Walter H Hörl; Gerhard J Zlabinger
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

4.  Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin.

Authors:  Julie Bouckaert; Jenny Berglund; Mark Schembri; Erwin De Genst; Lieve Cools; Manfred Wuhrer; Chia-Suei Hung; Jerome Pinkner; Rikard Slättegård; Anton Zavialov; Devapriya Choudhury; Solomon Langermann; Scott J Hultgren; Lode Wyns; Per Klemm; Stefan Oscarson; Stefan D Knight; Henri De Greve
Journal:  Mol Microbiol       Date:  2005-01       Impact factor: 3.501

5.  Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli.

Authors:  Joel D Schilling; Robin G Lorenz; Scott J Hultgren
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.

Authors:  S Langermann; R Möllby; J E Burlein; S R Palaszynski; C G Auguste; A DeFusco; R Strouse; M A Schenerman; S J Hultgren; J S Pinkner; J Winberg; L Guldevall; M Söderhäll; K Ishikawa; S Normark; S Koenig
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

7.  Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli.

Authors:  M Arthur; C E Johnson; R H Rubin; R D Arbeit; C Campanelli; C Kim; S Steinbach; M Agarwal; R Wilkinson; R Goldstein
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

8.  Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis.

Authors:  P Goluszko; S L Moseley; L D Truong; A Kaul; J R Williford; R Selvarangan; S Nowicki; B Nowicki
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

9.  Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection.

Authors:  B Foxman; L Zhang; P Tallman; K Palin; C Rode; C Bloch; B Gillespie; C F Marrs
Journal:  J Infect Dis       Date:  1995-12       Impact factor: 5.226

Review 10.  Pathogenesis of urinary tract infections with normal female anatomy.

Authors:  Gal Finer; Daniel Landau
Journal:  Lancet Infect Dis       Date:  2004-10       Impact factor: 25.071

View more
  1 in total

1.  [Medical therapy of urinary tract infection].

Authors:  G Stein; R Fünfstück
Journal:  Internist (Berl)       Date:  2008-06       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.